Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Variations in Screening Quality in a Federal Colorectal Cancer Screening Program for the Uninsured.

Nadel MR, Royalty J, Joseph D, Rockwell T, Helsel W, Kammerer W, Gray SC, Shapiro JA.

Prev Chronic Dis. 2019 May 30;16:E67. doi: 10.5888/pcd16.180452.

2.

Far From Home: An Examination of the Juvenile Visitation Experience and the Barriers to Getting There.

Young BC, Nadel MR, Bales WD, Pesta GB, Greenwald MA.

Int J Offender Ther Comp Criminol. 2019 Jun;63(8):1409-1423. doi: 10.1177/0306624X18823444.

PMID:
31064293
3.

Impact of Colonoscopy Bowel Preparation Quality on Follow-up Interval Recommendations for Average-risk Patients With Normal Screening Colonoscopies: Data From the New Hampshire Colonoscopy Registry.

Butterly LF, Nadel MR, Anderson JC, Robinson CM, Weiss JE, Lieberman D, Shapiro JA.

J Clin Gastroenterol. 2018 Aug 13. doi: 10.1097/MCG.0000000000001115. [Epub ahead of print]

PMID:
30106836
4.

Colorectal cancer screening in the United States: Trends from 2008 to 2015 and variation by health insurance coverage.

de Moor JS, Cohen RA, Shapiro JA, Nadel MR, Sabatino SA, Robin Yabroff K, Fedewa S, Lee R, Paul Doria-Rose V, Altice C, Klabunde CN.

Prev Med. 2018 Jul;112:199-206. doi: 10.1016/j.ypmed.2018.05.001. Epub 2018 May 3.

5.

A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening.

Shapiro JA, Bobo JK, Church TR, Rex DK, Chovnick G, Thompson TD, Zauber AG, Lieberman D, Levin TR, Joseph DA, Nadel MR.

Am J Gastroenterol. 2017 Nov;112(11):1728-1735. doi: 10.1038/ajg.2017.285. Epub 2017 Oct 10.

6.

Colorectal Cancer Screening in US Seniors Ages 76-84 Years.

Klabunde CN, Shapiro JA, Kobrin S, Nadel MR, Zapka JM.

J Community Health. 2015 Aug;40(4):769-79. doi: 10.1007/s10900-015-9998-z.

7.

Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.

Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M.

Cancer. 2013 Aug 1;119 Suppl 15:2940-6. doi: 10.1002/cncr.28155.

8.

Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.

Nadel MR, Royalty J, Shapiro JA, Joseph D, Seeff LC, Lane DS, Dwyer DM.

Cancer. 2013 Aug 1;119 Suppl 15:2834-41. doi: 10.1002/cncr.28164.

9.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

10.

Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.

Doria-Rose VP, White MC, Klabunde CN, Nadel MR, Richards TB, McNeel TS, Rodriguez JL, Marcus PM.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1049-59. doi: 10.1158/1055-9965.EPI-12-0343. Epub 2012 May 9.

11.

Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.

Shapiro JA, Klabunde CN, Thompson TD, Nadel MR, Seeff LC, White A.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):895-904. doi: 10.1158/1055-9965.EPI-12-0192. Epub 2012 Apr 6.

12.

Toward standardizing and reporting colorectal cancer screening indicators on an international level: The International Colorectal Cancer Screening Network.

Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P; International Colorectal Cancer Screening Network.

Int J Cancer. 2012 Jun 15;130(12):2961-73. doi: 10.1002/ijc.26310. Epub 2011 Aug 30.

13.

Trends in colorectal cancer test use among vulnerable populations in the United States.

Klabunde CN, Cronin KA, Breen N, Waldron WR, Ambs AH, Nadel MR.

Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1611-21. doi: 10.1158/1055-9965.EPI-11-0220. Epub 2011 Jun 8.

14.

Improving colorectal cancer screening outcomes: proceedings of the second meeting of the International Colorectal Cancer Screening Network, a global quality initiative.

Atkin WS, Benson VS, Green J, Monk CR, Nadel MR, Patnick J, Smith RA, Villain P.

J Med Screen. 2010;17(3):152-7. doi: 10.1258/jms.2010.010002.

PMID:
20956726
15.

Quality assessment of colonoscopy reporting: results from a statewide cancer screening program.

Li J, Nadel MR, Poppell CF, Dwyer DM, Lieberman DA, Steinberger EK.

Diagn Ther Endosc. 2010;2010. pii: 419796. doi: 10.1155/2010/419796. Epub 2010 Sep 28.

16.

The quality of colonoscopy services--responsibilities of referring clinicians: a consensus statement of the Quality Assurance Task Group, National Colorectal Cancer Roundtable.

Fletcher RH, Nadel MR, Allen JI, Dominitz JA, Faigel DO, Johnson DA, Lane DS, Lieberman D, Pope JB, Potter MB, Robin DP, Schroy PC 3rd, Smith RA.

J Gen Intern Med. 2010 Nov;25(11):1230-4. doi: 10.1007/s11606-010-1446-2. Epub 2010 Aug 12.

17.

Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious deviations from evidence-based recommendations.

Nadel MR, Berkowitz Z, Klabunde CN, Smith RA, Coughlin SS, White MC.

J Gen Intern Med. 2010 Aug;25(8):833-9. doi: 10.1007/s11606-010-1328-7. Epub 2010 Apr 10.

18.

Hormone therapy and fatal breast cancer.

Norman SA, Weber AL, Localio AR, Marchbanks PA, Ursin G, Strom BL, Weiss LK, Burkman RT, Bernstein L, Deapen DM, Folger SG, Simon MS, Nadel MR.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):440-7. doi: 10.1002/pds.1941.

19.

Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007.

Klabunde CN, Lanier D, Nadel MR, McLeod C, Yuan G, Vernon SW.

Am J Prev Med. 2009 Jul;37(1):8-16. doi: 10.1016/j.amepre.2009.03.008. Epub 2009 May 13.

20.

Colorectal cancer test use from the 2005 National Health Interview Survey.

Shapiro JA, Seeff LC, Thompson TD, Nadel MR, Klabunde CN, Vernon SW.

Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1623-30. doi: 10.1158/1055-9965.EPI-07-2838.

21.

Assessment of the scientific soundness of clinical performance measures: a field test of the National Committee for Quality Assurance's colorectal cancer screening measure.

Schneider EC, Nadel MR, Zaslavsky AM, McGlynn EA.

Arch Intern Med. 2008 Apr 28;168(8):876-82. doi: 10.1001/archinte.168.8.876.

PMID:
18443264
22.

Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults.

Berkowitz Z, Hawkins NA, Peipins LA, White MC, Nadel MR.

J Am Geriatr Soc. 2008 Feb;56(2):307-14. Epub 2007 Dec 7.

PMID:
18070002
23.

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

Benson VS, Patnick J, Davies AK, Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network.

Int J Cancer. 2008 Mar 15;122(6):1357-67.

24.

Protection of mammography screening against death from breast cancer in women aged 40-64 years.

Norman SA, Russell Localio A, Weber AL, Coates RJ, Zhou L, Bernstein L, Malone KE, Marchbanks PA, Weiss LK, Lee NC, Nadel MR.

Cancer Causes Control. 2007 Nov;18(9):909-18. Epub 2007 Jul 31.

PMID:
17665313
25.

Benefit of screening mammography in reducing the rate of late-stage breast cancer diagnoses (United States).

Norman SA, Localio AR, Zhou L, Weber AL, Coates RJ, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Lee NC, Nadel MR.

Cancer Causes Control. 2006 Sep;17(7):921-9.

PMID:
16841259
26.

Colorectal cancer test use among Hispanic and non-Hispanic U.S. populations.

Pollack LA, Blackman DK, Wilson KM, Seeff LC, Nadel MR.

Prev Chronic Dis. 2006 Apr;3(2):A50. Epub 2006 Mar 15.

27.

Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average-risk adults.

Klabunde CN, Vernon SW, Nadel MR, Breen N, Seeff LC, Brown ML.

Med Care. 2005 Sep;43(9):939-44.

PMID:
16116360
28.

A national survey of primary care physicians' methods for screening for fecal occult blood.

Nadel MR, Shapiro JA, Klabunde CN, Seeff LC, Uhler R, Smith RA, Ransohoff DF.

Ann Intern Med. 2005 Jan 18;142(2):86-94.

PMID:
15657156
29.

How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.

Seeff LC, Richards TB, Shapiro JA, Nadel MR, Manninen DL, Given LS, Dong FB, Winges LD, McKenna MT.

Gastroenterology. 2004 Dec;127(6):1670-7.

PMID:
15578503
30.

Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?

Seeff LC, Manninen DL, Dong FB, Chattopadhyay SK, Nadel MR, Tangka FK, Molinari NA.

Gastroenterology. 2004 Dec;127(6):1661-9.

PMID:
15578502
31.

Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research.

Vernon SW, Meissner H, Klabunde C, Rimer BK, Ahnen DJ, Bastani R, Mandelson MT, Nadel MR, Sheinfeld-Gorin S, Zapka J.

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):898-905. No abstract available.

32.

Patterns and predictors of colorectal cancer test use in the adult U.S. population.

Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ.

Cancer. 2004 May 15;100(10):2093-103.

33.

Validation of self-reported screening mammography histories among women with and without breast cancer.

Norman SA, Localio AR, Zhou L, Bernstein L, Coates RJ, Flagg EW, Marchbanks PA, Malone KE, Weiss LK, Lee NC, Nadel MR.

Am J Epidemiol. 2003 Aug 1;158(3):264-71.

PMID:
12882949
34.

Complications of screening flexible sigmoidoscopy.

Levin TR, Conell C, Shapiro JA, Chazan SG, Nadel MR, Selby JV.

Gastroenterology. 2002 Dec;123(6):1786-92.

PMID:
12454834
35.
36.

Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey.

Nadel MR, Blackman DK, Shapiro JA, Seeff LC.

Prev Med. 2002 Sep;35(3):199-206.

PMID:
12202061
37.

Colorectal cancer-screening tests and associated health behaviors.

Shapiro JA, Seeff LC, Nadel MR.

Am J Prev Med. 2001 Aug;21(2):132-7.

PMID:
11457633
38.

Colorectal cancer screening participation by older women.

Mandelson MT, Curry SJ, Anderson LA, Nadel MR, Lee NC, Rutter CM, LaCroix AZ.

Am J Prev Med. 2000 Oct;19(3):149-54.

PMID:
11020590
39.

Surveillance for use of preventive health-care services by older adults, 1995-1997.

Janes GR, Blackman DK, Bolen JC, Kamimoto LA, Rhodes L, Caplan LS, Nadel MR, Tomar SL, Lando JF, Greby SM, Singleton JA, Strikas RA, Wooten KG.

MMWR CDC Surveill Summ. 1999 Dec 17;48(8):51-88.

PMID:
10634271
40.
41.
42.

Cervical cancer screening and demonstration projects to identify barriers to preventing cervical cancer mortality.

Taylor WR, Nadel MR, Smith RA, Hernandez C, Moser M, Friedell GH.

Acta Cytol. 1989 Jul-Aug;33(4):460-2.

PMID:
2546348
43.

Increase in high-grade lymphomas in young men.

Boring CC, Brynes RK, Chan WC, Causey N, Gregory HR, Nadel MR, Greenberg RS.

Lancet. 1985 Apr 13;1(8433):857-9.

PMID:
2858716
44.

Cytogenetic findings in persons living near the Love Canal.

Heath CW Jr, Nadel MR, Zack MM Jr, Chen AT, Bender MA, Preston RJ.

JAMA. 1984 Mar 16;251(11):1437-40.

PMID:
6700040
45.

Love canal.

Heath CW Jr, Nadel MR, Zack MM, Chen AT, Bender MA, Preston RJ.

Science. 1983 Sep 2;221(4614):908. No abstract available.

PMID:
6879190
46.

Effect of the pleiotropic GrB mutation of Bombyx mori on chorion protein synthesis.

Nadel MR, Thireos G, Kafatos FC.

Cell. 1980 Jul;20(3):649-58. No abstract available.

PMID:
7418003
47.

Specific protein synthesis in cellular differentiation. V. A secretory defect of chorion formation in the Grcol mutant of Bombyx mori.

Nadel MR, Goldsmith MR, Goplerud J, Kafatos FC.

Dev Biol. 1980 Mar;75(1):41-58. No abstract available.

PMID:
7371994
48.
49.

The eggshell of insects: differentiation-specific proteins and the control of their synthesis and accumulation during development.

Kafatos FC, Regier JC, Mazur GD, Nadel MR, Blau HM, Petri WH, Wyman AR, Gelinas RE, Moore PB, Paul M, Efstratiadis A, Vournakis JN, Goldsmith MR, Hunsley JR, Baker B, Nardi J, Koehler M.

Results Probl Cell Differ. 1977;8:45-145. Review. No abstract available.

PMID:
335468
50.

Surface ultramicroscopy of sickle cells.

Farnsworth PN, Nadel MR, Stoll BJ.

Nature. 1970 Jan 10;225(5228):190-1. No abstract available.

PMID:
5409968

Supplemental Content

Loading ...
Support Center